In Brief: Advertising and promotion teleconference
This article was originally published in The Gray Sheet
Executive Summary
Advertising and promotion teleconference: FDA and the Food and Drug Law Institute are co-sponsoring a teleconference slated for May 4 on FDA regulation of device, drug and biologics promotional activity. Specific issues to be discussed include: FDA's draft policy on continuing medical education; direct-to-consumer promotion; and the effect of marketing and advertising issues on efforts to better educate health professionals and facilitate public health. Speakers will include Byron Tart, director of the FDA device center's promotion and advertising policy staff, and William Purvis, director of the advertising and promotional labeling staff at the agency's Center for Biologics Evaluation and Research. For more information, contact FDLI at 202/371-1420...